(Q58377593)

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Protein tyrosine phosphatase function: the substrate perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Protein-tyrosine phosphatases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Inside the human cancer tyrosine phosphatome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

A role for the scaffolding adapter GAB2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

A brake becomes an accelerator: PTP1B--a new therapeutic target for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Mutational analysis of the tyrosine phosphatome in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Association of the T-cell protein tyrosine phosphatase with nuclear import factor p97

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Evidence for a role of transmembrane protein p25 in localization of protein tyrosine phosphatase TC48 to the ER

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

AMPK, the metabolic syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activating SRC mutation in a subset of advanced human colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

21 January 2018

A renaissance for SRC

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

LKB1, a protein kinase regulating cell proliferation and polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Identification of a nuclear Stat1 protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Tyrosine phosphorylation of a SNARE protein, syntaxin 17: implications for membrane trafficking in the early secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in ptpn2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T-cell protein tyrosine phosphatase regulates bone resorption and whole-body insulin sensitivity through its expression in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Inhibition of T cell protein tyrosine phosphatase enhances interleukin-18-dependent hematopoietic stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Oncogenic kinase signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Targeting MET in cancer: rationale and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

EGFR family: structure physiology signalling and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Checking on DNA damage in S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Replication checkpoint control by a PTK/STAT3/cyclin D1 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Molecular pathogenesis of T-cell leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The molecular basis of T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Imatinib and beyond--exploring the full potential of targeted therapy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Central tolerance: learning self-control in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

The TLX1 oncogene drives aneuploidy in T cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Triple-negative breast cancers: an updated review on treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Biology of HER2 and its importance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Evaluation of potential Stat3-regulated genes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Targeting Src in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Alternative and aberrant splicing of MDM2 mRNA in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5

Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3649-6_5